Testing the best electrical settings for ECT for depression
Part of Mental health clinical trials.
This trial studies which electrical “pulse settings” work best during electroconvulsive therapy (ECT) for people with depression. It may help doctors personalize ECT so the treatment is safer and works as well as possible for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have a diagnosis of a depression episode (unipolar or bipolar) as defined by ICD-10.
- A clinician has recommended ECT, and you agree to have ECT.
- You have a Swedish personal identity number.
- You are able to understand the study and sign informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of transcranial magnetic stimulation (TMS) to see which works better for people with depression. TMS uses magnetic pulses to stimulate brain areas involved in mood regulation.
This study looks at how to best set the electrical stimulation for electroconvulsive therapy (ECT), a treatment for severe depression and other mental health conditions. The goal is to improve how well ECT works while possibly reducing side effects.
This trial studies better ways to deliver ECT (electroconvulsive therapy) for people with difficult-to-treat depression, including some people with bipolar depression. You may be offered an ECT strategy that’s tailored to your situation, with the goal of improving outcomes and reducing problems.
This study looks at how ECT affects brain activity and inflammation in older adults with depression. It may help researchers understand why ECT works and improve treatment.
This trial tests a new type of seizure therapy (low amplitude pulse seizure therapy) against the standard ultra-brief right unilateral ECT for people with severe depression, including those with suicidal thoughts. The goal is to see which treatment works better.
This study measures changes in your blood and/or body chemistry while you receive electroconvulsive therapy (ECT) for a severe mood episode. The goal is to understand biological signals related to ECT and treatment-resistant depression, which may help improve future care.
Hear when a new Depressive Disorder, Major trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.